Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
---|---|---|---|---|---|
6530 Q-TOF/C18 NEGATIVE ION MODE | LYSINE (M-H)- | 2510 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | LYSINE (M-H)- | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | LYSINE (M-H)- | Peak area | MCN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | LYSINE (M-H)- | Peak area | SCA | N/A | |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 2682 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 11408 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 14522 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 58458 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 77575 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 97942 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | 120805 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+H)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | 2130 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | 16957 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | 21920 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | 26899 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | Peak area | MCN | LGD | |
6530 Q-TOF/C18 POSITIVE ION MODE | LYSINE (M+Na)+ | Peak area | SCA | N/A |